Personal Accounts of Young-Onset Colorectal Cancer Organized as Patient-Reported Data: Protocol for a Mixed Methods Study.
PROMs
cancer
colorectal cancer
patient reported outcome
young-onset cancer
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
26 Feb 2021
26 Feb 2021
Historique:
received:
15
10
2020
accepted:
21
01
2021
revised:
12
01
2021
entrez:
26
2
2021
pubmed:
27
2
2021
medline:
27
2
2021
Statut:
epublish
Résumé
Young-onset colorectal cancer is a contemporary issue in need of substantial research input. The incidence of colorectal cancer in adults younger than 50 years is rising in contrast to the decreasing incidence of this cancer in older adults. People with young-onset colorectal cancer may be at that stage of life in which they are establishing their careers, building relationships with long-term partners, raising children, and assembling a financial base for the future. A qualitative study designed to facilitate triangulation with extant quantitative patient-reported data would contribute the first comprehensive resource for understanding how this distinct patient population experiences health services and the outcomes of care throughout the patient pathway. The aim of this study was to undertake a mixed-methods study of qualitative patient-reported data on young-onset colorectal cancer experiences and outcomes. This is a study of web-based unsolicited patient stories recounting experiences of health services and clinical outcomes related to young-onset colorectal cancer. Personal Recollections Organized as Data (PROD) is a novel methodology for understanding patients' health experiences in order to improve care. PROD pivots qualitative data collection and analysis around the validated domains and dimensions measured in patient-reported outcome and patient-reported experience questionnaires. PROD involves 4 processes: (1) classifying attributes of the contributing patients, their disease states, their routes to diagnosis, and the clinical features of their treatment and posttreatment; (2) coding texts into the patient-reported experience and patient-reported outcome domains and dimensions, defined a priori, according to phases of the patient pathway; (3) thematic analysis of content within and across each domain; and (4) quantitative text analysis of the narrative content. Relevant patient stories have been identified, and permission has been obtained for use of the texts in primary research. The approval for this study was granted by the Macquarie University Human Research Ethics Committee in June 2020. The analytical framework was established in September 2020, and data collection commenced in October 2020. We will complete the analysis in March 2021 and we aim to publish the results in mid-2021. The findings of this study will identify areas for improvement in the PROD methodology and inform the development of a large-scale study of young-onset colorectal cancer patient narratives. We believe that this will be the first qualitative study to identify and describe the patient pathway from symptom self-identification to help-seeking through to diagnosis, treatment, and to survivorship or palliation for people with young-onset colorectal cancer. DERR1-10.2196/25056.
Sections du résumé
BACKGROUND
BACKGROUND
Young-onset colorectal cancer is a contemporary issue in need of substantial research input. The incidence of colorectal cancer in adults younger than 50 years is rising in contrast to the decreasing incidence of this cancer in older adults. People with young-onset colorectal cancer may be at that stage of life in which they are establishing their careers, building relationships with long-term partners, raising children, and assembling a financial base for the future. A qualitative study designed to facilitate triangulation with extant quantitative patient-reported data would contribute the first comprehensive resource for understanding how this distinct patient population experiences health services and the outcomes of care throughout the patient pathway.
OBJECTIVE
OBJECTIVE
The aim of this study was to undertake a mixed-methods study of qualitative patient-reported data on young-onset colorectal cancer experiences and outcomes.
METHODS
METHODS
This is a study of web-based unsolicited patient stories recounting experiences of health services and clinical outcomes related to young-onset colorectal cancer. Personal Recollections Organized as Data (PROD) is a novel methodology for understanding patients' health experiences in order to improve care. PROD pivots qualitative data collection and analysis around the validated domains and dimensions measured in patient-reported outcome and patient-reported experience questionnaires. PROD involves 4 processes: (1) classifying attributes of the contributing patients, their disease states, their routes to diagnosis, and the clinical features of their treatment and posttreatment; (2) coding texts into the patient-reported experience and patient-reported outcome domains and dimensions, defined a priori, according to phases of the patient pathway; (3) thematic analysis of content within and across each domain; and (4) quantitative text analysis of the narrative content.
RESULTS
RESULTS
Relevant patient stories have been identified, and permission has been obtained for use of the texts in primary research. The approval for this study was granted by the Macquarie University Human Research Ethics Committee in June 2020. The analytical framework was established in September 2020, and data collection commenced in October 2020. We will complete the analysis in March 2021 and we aim to publish the results in mid-2021.
CONCLUSIONS
CONCLUSIONS
The findings of this study will identify areas for improvement in the PROD methodology and inform the development of a large-scale study of young-onset colorectal cancer patient narratives. We believe that this will be the first qualitative study to identify and describe the patient pathway from symptom self-identification to help-seeking through to diagnosis, treatment, and to survivorship or palliation for people with young-onset colorectal cancer.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
DERR1-10.2196/25056.
Identifiants
pubmed: 33635274
pii: v10i2e25056
doi: 10.2196/25056
pmc: PMC7954655
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e25056Informations de copyright
©Klay Lamprell, Diana Fajardo Pulido, Yvonne Tran, Bróna Nic Giolla Easpaig, Winston Liauw, Gaston Arnolda, Jeffrey Braithwaite. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 26.02.2021.
Références
J Patient Exp. 2014 May;1(1):20-22
pubmed: 28725797
BMC Med. 2018 Jun 20;16(1):92
pubmed: 29921274
BMJ Open. 2018 Oct 21;8(10):e025896
pubmed: 30344183
Qual Health Res. 2003 Sep;13(7):905-23
pubmed: 14502957
Qual Manag Health Care. 1994 Summer;2(4):28-35
pubmed: 10137605
BMC Health Serv Res. 2012 Aug 22;12:271
pubmed: 22913525
Mayo Clin Proc. 2014 Feb;89(2):216-24
pubmed: 24393412
BMJ Open. 2013 Jan 03;3(1):
pubmed: 23293244
Curr Treat Options Oncol. 2017 Apr;18(4):23
pubmed: 28391421
Cancer Med. 2019 Jan;8(1):155-164
pubmed: 30525298
J Med Internet Res. 2020 Mar 26;22(3):e15772
pubmed: 32213468
Cancer. 2016 Mar 15;122(6):929-34
pubmed: 26808454
N Engl J Med. 2013 Jun 27;368(26):2445-8
pubmed: 23802513
BMC Med Inform Decis Mak. 2016 Nov 3;16(1):138
pubmed: 27809908
Gut. 2019 Dec;68(12):2179-2185
pubmed: 31488504
BMJ Open. 2014 Jul 22;4(7):e005601
pubmed: 25052175
Support Care Cancer. 2016 Aug;24(8):3661-8
pubmed: 27193118
PLoS One. 2017 Aug 23;12(8):e0183031
pubmed: 28832603
BMJ Qual Saf. 2016 Aug;25(8):604-14
pubmed: 26512131
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
J Clin Epidemiol. 2015 Mar;68(3):266-78
pubmed: 25455838
Qual Life Res. 2015 Oct;24(10):2457-72
pubmed: 26012839
J Adv Nurs. 2010 Aug;66(8):1671-82
pubmed: 20557382
Oncol Nurs Forum. 2014 Sep;41(5):545-7
pubmed: 25158659
Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):83-90
pubmed: 30530848
Value Health. 2013 Jan-Feb;16(1):76-87
pubmed: 23337218
J Healthc Manag. 2014 Jan-Feb;59(1):31-47
pubmed: 24611424
BMC Health Serv Res. 2014 Oct 22;14:499
pubmed: 25331177
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):511-518
pubmed: 31105047
Clin Colorectal Cancer. 2017 Dec;16(4):293-299.e6
pubmed: 29033218
Nurse Res. 2011;18(2):52-62
pubmed: 21319484
Public Health Res Pract. 2017 Dec 7;27(5):
pubmed: 31044216
Qual Health Res. 2018 Aug;28(10):1564-1583
pubmed: 29173015
Health Serv Res. 2019 Oct;54(5):1023-1035
pubmed: 31218671
Patient Educ Couns. 2011 Sep;84(3):352-8
pubmed: 21621950
Ecancermedicalscience. 2013 Oct 10;7:361
pubmed: 24143155
Br J Cancer. 2015 Mar 31;112 Suppl 1:S35-40
pubmed: 25734380
Drug Saf. 2013 Dec;36(12):1129-49
pubmed: 24092596
Med J Aust. 2016 Nov 21;205(10):465-470
pubmed: 27852185
World J Gastroenterol. 2017 Jul 28;23(28):5041-5044
pubmed: 28811701
J Nurs Scholarsh. 2001;33(1):93-6
pubmed: 11253591
J Gastrointest Cancer. 2020 Mar;51(1):196-203
pubmed: 30977049
Am J Surg. 2013 Mar;205(3):312-6; discussion 316
pubmed: 23414955
BMJ Open. 2013 Apr 10;3(4):
pubmed: 23578681
BMJ. 2015 Feb 10;350:g7818
pubmed: 25670183
Eur J Cancer. 2006 Aug;42(12):1848-57
pubmed: 16829069
BMC Public Health. 2011 Jul 29;11:604
pubmed: 21798072
Patient Relat Outcome Meas. 2017 Nov 08;8:133-142
pubmed: 29184455
J Clin Oncol. 2004 Dec 1;22(23):4829-36
pubmed: 15570086
Future Oncol. 2019 Apr;15(10):1135-1146
pubmed: 30880455
Clin Ther. 2016 Jul;38(7):1600-21
pubmed: 27045993
J Patient Rep Outcomes. 2020 Apr 25;4(1):27
pubmed: 32335745
Lancet Oncol. 2016 Nov;17(11):e510-e514
pubmed: 27769798